Veeva Systems (VEEV) Scheduled to Post Earnings on Tuesday


Share on StockTwits

Veeva Systems (NYSE:VEEV) is set to post its quarterly earnings results after the market closes on Tuesday, March 2nd. Analysts expect Veeva Systems to post earnings of $0.45 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings data on Monday, November 30th. The technology company reported $0.78 EPS for the quarter, beating the Zacks’ consensus estimate of $0.68 by $0.10. Veeva Systems had a net margin of 24.88% and a return on equity of 15.73%. The firm had revenue of $377.52 million for the quarter, compared to the consensus estimate of $361.86 million. During the same period in the previous year, the firm posted $0.60 earnings per share. The firm’s revenue was up 34.4% on a year-over-year basis. On average, analysts expect Veeva Systems to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Shares of VEEV opened at $293.11 on Tuesday. The company’s 50 day moving average price is $291.61 and its 200 day moving average price is $279.86. Veeva Systems has a 52 week low of $118.11 and a 52 week high of $325.54. The company has a market capitalization of $44.40 billion, a PE ratio of 136.97, a PEG ratio of 9.41 and a beta of 0.84.

A number of brokerages recently commented on VEEV. Needham & Company LLC boosted their price objective on shares of Veeva Systems from $310.00 to $327.00 and gave the company a “buy” rating in a research report on Wednesday, December 2nd. DA Davidson reaffirmed a “buy” rating on shares of Veeva Systems in a research report on Wednesday, December 2nd. JPMorgan Chase & Co. downgraded shares of Veeva Systems from a “neutral” rating to an “underweight” rating and set a $297.00 price objective on the stock. in a research report on Wednesday, December 9th. Piper Sandler lifted their target price on shares of Veeva Systems from $310.00 to $340.00 in a research note on Monday, January 11th. Finally, Morgan Stanley lifted their target price on shares of Veeva Systems from $323.00 to $332.00 and gave the company an “overweight” rating in a research note on Wednesday, December 2nd. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $290.96.

In other Veeva Systems news, EVP Alan Mateo sold 2,666 shares of the business’s stock in a transaction on Friday, February 5th. The shares were sold at an average price of $290.21, for a total value of $773,699.86. Following the sale, the executive vice president now owns 4,610 shares of the company’s stock, valued at approximately $1,337,868.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Frederic Lequient sold 359 shares of the business’s stock in a transaction on Friday, December 11th. The shares were sold at an average price of $265.64, for a total transaction of $95,364.76. Following the completion of the sale, the senior vice president now directly owns 387 shares in the company, valued at approximately $102,802.68. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 38,901 shares of company stock valued at $10,760,730. Corporate insiders own 14.38% of the company’s stock.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, commercial data warehouse, allocation and alignment applications, master data management application, and data and services; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety.

Read More: What is the Difference Between Common Shares and Convertible Shares?

Earnings History for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.